After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. The stock was recently discussed on Yahoo Finance as it revealed that Organon’s XACIATO™ (clindamycin phosphate) Vaginal Gel 2% Available Nationwide to Treat Bacterial Vaginosis (BV) in Females Aged 12 and Older.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
As a NYSE listed company, OGN falls under the Healthcare sector while operating within the Drug Manufacturers – General industry segment. At the end of the last regular session, the stock closed at $16.59 and fluctuated between $16.78 as its day high and $16.33 as its day low. The current market capitalization of Organon & Co. is $4.24B. A total of 3.03 million shares were traded on the day, compared to an average of 5.74M shares.
Aside from predicting where a stock will go, investors also consider insider trades as an indicator of the stock’s future direction. During the recent three months, OGN has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 41 BUYs and 41 SELLs from insiders. Insiders purchased 225,397 shares during that period but sold 94,715.
Dividend
Investors prefer companies that pay dividends because dividends generate immediate cash flow and indicate a positive outlook. Organon & Co. pays an annual dividend of $1.12, resulting in a dividend yield of 6.77%, and it has a price to earnings (P/E) ratio of 7.26. OGN’s most recent ex-dividend date was 11/10/2023 when it declared a $0.28 quarterly dividend that was paid in cash on 12/14/2023. Previously, the company paid the dividend on 9/14/2023 with an ex-dividend date of 8/17/2023. The OGN stock dividend was $0.28 per share in cash.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, OGN has a high of $32.43 and a low of $10.84.
As of this writing, OGN has an earnings estimate of $Organigram Holdings Inc. per share for the current quarter. EPS was calculated based on a consensus of ON Semiconductor Corporation estimates, with a high estimate of $Ocugen, Inc. per share and a lower estimate of $Organon & Co.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. OGN’s latest balance sheet shows that the firm has $737.00M in Cash & Short Term Investments as of fiscal 2021. There were $9.13B in debt and $2.60B in liabilities at the time. Its Book Value Per Share was -$2.30, while its Total Shareholder’s Equity was -$1.51B.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for OGN is Buy with a score of 3.43.
